Creatd Sells Flyte, Inc. for $11.55M; Registers 180,030 Shares for Resale
Creatd, Inc. sold its entire 80.02% equity interest in Fly Flyte, Inc. to Catheter Precision, Inc. for $11.55 million, consisting of $5.78 million in cash and $5.78 million in VTAK Preferred Series D Stock. The company also filed an S-1 registration statement for the resale of up to 180,030 shares of common stock by selling stockholders, from which Creatd will not receive direct proceeds. Additionally, Creatd detailed recent financing activities, including partially funded tranches of a $7.78 million convertible note and warrant offering, with remaining obligations released following the Fly Flyte sale. The company reported a net loss of $9.4 million for the year ended December 31, 2025, and faces a going concern warning.
Key Highlights
- Sold 80.02% equity interest in Fly Flyte, Inc. for $11.55 million.
- Received $5.78 million cash and $5.78 million in VTAK Preferred Series D Stock from the sale.
- Filed S-1 registration for resale of up to 180,030 common shares by selling stockholders.
- Funded $2.18 million gross from the first two tranches of a $7.78 million uplist financing.
- Purchasers released from remaining financing obligations after Fly Flyte sale.
- Implemented a 1-for-20 reverse stock split on February 24, 2026.
- Reported a net loss of $9.4 million for the year ended December 31, 2025.
- Had a working capital deficit of $7.9 million and accumulated deficit of $262.9 million.
Price Impact
More from CRTD